SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE - A REVIEW OF 9 YEARS EXPERIENCE WITH BROMOCRIPTINE

被引：9

作者：

LIEBERMAN, AN ^{[1
]}

机构：

[1] NYU,SCH MED,DEPT NEUROL,NEW YORK,NY 10016

来源：

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1984年 / 11卷 / 01期

关键词：

D O I：

10.1017/S0317167100046473

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：233 / 237

页数：5

共 14 条

[1]

CALNE DB, 1978, LANCET, V1, P735

[2]

GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P235

[3] BROMOCRIPTINE IN PARKINSONISM - LONG-TERM STUDY [J].

LEES, AJ ;

HADDAD, S ;

SHAW, KM ;

KOHOUT, LJ ;

STERN, GM .

ARCHIVES OF NEUROLOGY, 1978, 35 (08) :503-505

[4] DEMENTIA IN PARKINSON DISEASE [J].

LIEBERMAN, A ;

DZIATOLOWSKI, M ;

KUPERSMITH, M ;

SERBY, M ;

GOODGOLD, A ;

KOREIN, J ;

GOLDSTEIN, M .

ANNALS OF NEUROLOGY, 1979, 6 (04) :355-359

[5] LONG-TERM EFFICACY OF BROMOCRIPTINE IN PARKINSON DISEASE [J].

LIEBERMAN, A ;

KUPERSMITH, M ;

NEOPHYTIDES, A ;

CASSON, I ;

DURSO, R ;

FOO, SH ;

KHAYALI, M ;

BEAR, G ;

GOLDSTEIN, M .

NEUROLOGY, 1980, 30 (05) :518-523

[6] TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE [J].

LIEBERMAN, A ;

KUPERSMITH, M ;

ESTEY, E ;

GOLDSTEIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (25) :1400-1404

[7]

Lieberman A, 1980, Adv Biochem Psychopharmacol, V23, P277

[8] ANTIPARKINSONIAN EFFICACY OF BROMOCRIPTINE [J].

LIEBERMAN, A ;

ZOLFAGHARI, M ;

BOAL, D ;

HASSOURI, H ;

VOGEL, B ;

BATTISTA, A ;

FUXE, K ;

GOLDSTEIN, M .

NEUROLOGY, 1976, 26 (05) :405-409

[9]

Lieberman A N, 1983, Adv Neurol, V37, P95

[10] BROMOCRIPTINE IN PARKINSON DISEASE - FURTHER-STUDIES [J].

LIEBERMAN, AN ;

KUPERSMITH, M ;

GOPINATHAN, G ;

ESTEY, E ;

GOODGOLD, A ;

GOLDSTEIN, M .

NEUROLOGY, 1979, 29 (03) :363-369

← 1 2 →